On Friday shares of Daqo New Energy Corp. (NYSE:DQ) closed at $29.20. Company’s sales growth for last 5 years was 14.10%. On April 10, Daqo New Energy Corp. (NYSE:DQ) announced its unaudited financial results for the fourth quarter and fiscal year of 2014. Record-high quarterly polysilicon production volume of 1,791 MT in Q4 2014, up from 1,748 MT in Q3 2014. Polysilicon shipments of 1,537 MT in Q4 2014, compared to 1,598 MT in Q3 2014
Sequential Brands Group, Inc. (NASDAQ:SQBG) has 23.20% insider ownership while its institutional ownership stands at 74.90%. In last trading activity company’s stock closed at $13.96. On April 8, Sequential Brands Group, Inc. (NASDAQ:SQBG) announced that it has closed the acquisition of the Jessica Simpson brand. The Company has acquired a majority interest in the brand, including the Jessica Simpson Collection master license and other rights. The Company is projecting forward 12-month royalty revenues of $88.0 – $90.0 million and $53.5 – $55.0 million of Adjusted EBITDA from the Company’s total brand portfolio.
On Friday shares of The Travelers Companies, Inc. (NYSE:TRV) closed at $107.65. Company’s sales growth for last 5 years was 1.90% and EPS growth for next 5 years is recorded as 5.48%. Property casualty insurance provider Travelers Companies, Inc. (NYSE:TRV) said it has agreed to acquire a majority interest in the property casualty business of its J. Malucelli joint venture in Brazil.
Legg Mason Inc. (NYSE:LM) in last trading activity fell -0.87% to close at $54.43. Company weekly performance is -2.07% while its quarterly performance stands at 1.23%. Legg Mason Inc. (NYSE:LM) is -7.77% away from its 52 week high. Legg Mason, Inc. (NYSE:LM) reported preliminary assets under management of $702.7 billion as of March 31, 2015. This month’s AUM included preliminary long-term inflows of $2.6 billion, driven by fixed income inflows of $3.9 billion. Equity and Liquidity outflows were $1.3 billion and $6.5 billion, respectively. March AUM included a negative foreign exchange impact of $3.2 billion
On last trading day Aeterna Zentaris Inc. (NASDAQ:AEZS) fell -1.32% to close at $0.52. Its volatility for the week is 4.03% while volatility for the month is 6.44%. AEZS’s EPS growth for past 5 years was 30.40%. Aeterna Zentaris Inc. (NASDAQ:AEZS) monthly performance is -2.81%. Aeterna Zentaris Inc. (NASDAQ:AEZS) announced plans to conduct a new, confirmatory Phase 3 clinical study to demonstrate the efficacy of Macrilen™ (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency (“AGHD”), as well as a dedicated thorough QT study to evaluate the effect of Macrilen™ on myocardial repolarization. This decision follows a positive and helpful meeting with the U.S. Food and Drug Administration (“FDA”) regarding its New Drug Application for Macrilen™.